Vident Investment Advisory’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,639	Closed	-$402K	–	399
2015 Q3	$402K	Buy	12,639 +5,090	+67%	+$162K	0.06%	622
2015 Q2	$249K	Buy	7,549 +279	+4%	+$9.2K	0.03%	717
2015 Q1	$299K	Buy	+7,270	New	+$299K	0.06%	636